NCT04915469

Brief Summary

Viral suppression among children and adolescents in Kenya is currently sub-optimal at 60% and 63% respectively. Under the current Kenya Ministry of Health Guidelines, clients with viral load of \>1000 copies/ml, should receive a minimum of three enhanced adherence counselling (EAC) sessions offered every two weeks and have a repeat viral load conducted 3 months after EAC completion. However, delivery of the EAC is not standardized and there is limited data available to evaluate the effectiveness of the three counselling sessions. Observational data from Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)-supported sites in Homa Bay and Turkana counties indicate that among children and adolescents with a viral load \> 1000 copies/ml, approximately 40% received the recommended three minimum EAC sessions and, after receiving EAC sessions, viral suppression was 33% in children aged below 9 years, 27% in adolescents aged between 10-14 years, 38% in adolescents aged 15 to 19 years and 53% in adults. The investigators propose to evaluate the implementation, effectiveness and acceptability of a standardized EAC package implemented at EGPAF-supported sites. Methods: The investigators will use mixed methods to evaluate specific clinical outcomes (viral suppression) adherence, retention) among children and adolescents who receive the EAC package after suspected treatment failure, and if applicable, after switch to second and third line. The investigators will use a pre/post intervention assessment to evaluate the effectiveness of the EAC package, and qualitative methods (in-depth individual interviews (IDI) and focus group discussions (FGD)) to identify facilitators and barriers to accessing EAC. A process evaluation will be conducted to determine whether the standardized EAC package has been implemented as intended across sites. The study population is defined as children aged 0-19 years receiving Antiretroviral therapy (ART) in selected EGPAF supported sites. Policy Significance: Dissemination of findings will be done through: internal evaluation report shared with stakeholders, donors, and the Ministry of Health (MOH) and abstracts presented at local and international conferences; and, manuscripts for publication in peer-reviewed journals. Findings are expected to inform the continuous review and improvement of HIV Program delivery in Kenya, as the ministry of health and partners strive to meet international standards.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
741

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 7, 2021

Completed
Last Updated

June 7, 2021

Status Verified

May 1, 2021

Enrollment Period

1.5 years

First QC Date

May 27, 2021

Last Update Submit

May 31, 2021

Conditions

Keywords

ChildrenAdolescentsViral suppressionAntiretroviral therapy

Outcome Measures

Primary Outcomes (1)

  • Viral Suppression

    Viral load will be done following completion of at least 3 enhanced adherence counselling sessions. a patient with a viral load less than 1000 copies/ml3, will be considered to have suppressed

    This will be done after 3 months of EAC

Secondary Outcomes (5)

  • Adherence to clinic visits and pharmacy pick-ups

    9 months

  • Retention on ART

    At 9 months

  • Lost to follow-up(LTFU)

    At 9 months

  • Time to 1st EAC following diagnosis of suspected treatment failure

    baseline

  • Average time to completion of EAC sessions

    at 3 months

Study Arms (2)

Pre-standardization group

NO INTERVENTION

Pre intervention- patient level data are abstracted retrospectively from the charts of patients with VL \>1000 copies/ml on demographic characteristics and clinical outcomes and facility level data from summary forms for up to 24 months prior to the implementation of the standardized EAC package.

Post-standardization group

OTHER

This group of participants will receive the standardized enhanced adherence package. After implementation of the standardized EAC package, data will be prospectively collected from participants with high viral load (\>1000 copies).

Other: Standardized enhanced adherence counseling package

Interventions

A standardized package was developed to support the adherence counsellor and other cadres to ensure provision of quality EAC sessions for children, adolescents and their caregivers. The package included; 1) Orientation and on job mentorship on EAC processes to clinicians, nurses, peer educators and mentor mothers. 2) Using a communication's training curriculum, providers were trained on psychosocial support and communication skills for children and their caregivers. 3) Appointment management was done using appointment dairies or a digital platform that sends patients short message services (SMS) reminders 3 days and 1 day before a scheduled clinic day. 4)Home visits. - All home visits were done according to the EGPAF standard operation procedures (SOPs) drawn from the Kenya National guidelines. 5) Individualized case management -Each EAC client was allocated a case manager who ensured that the barriers to adherence were identified and tackled both at individual and community level.

Post-standardization group

Eligibility Criteria

AgeUp to 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 0-19 years
  • HIV positive
  • On ART for at least 6 months
  • Last VL \>1000 copies
  • Parental/guardian consent
  • Assent (for 10-17-year old)
  • Consent (for 18-19-year old)
  • Parent/guardian to a child/adolescent on ART with VL\>1000 copies
  • Provides consent
  • Working in the facility for at least 3 months
  • Provides services to HIV positive children and adolescents on ART
  • Provides consent

You may not qualify if:

  • Already receiving EAC
  • Receiving services at non-participating facility
  • Not providing HIV services to children and adolescent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Homa Bay county

Homa Bay, Kenya

Location

Related Publications (1)

  • Gill MM, Ndimbii JN, Otieno-Masaba R, Ouma M, Jabuto S, Ochanda B. Adherence challenges and opportunities for optimizing care through enhanced adherence counseling for adolescents with suspected HIV treatment failure in Kenya. BMC Health Serv Res. 2022 Jul 29;22(1):962. doi: 10.1186/s12913-022-08373-9.

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Rose Masaba

    Elizabeth Glaser Pediatric AIDS Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a pre-post study design. The post-group receive an intervention of a standardized enhanced adherence counseling package
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Director Public Health Evaluations

Study Record Dates

First Submitted

May 27, 2021

First Posted

June 7, 2021

Study Start

March 4, 2019

Primary Completion

August 20, 2020

Study Completion

September 20, 2020

Last Updated

June 7, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations